Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Adenovirus-IL-10 relieves chronic rejection after mouse heart transplantation by inhibiting miR-155 and activating SOCS5.

International journal of medical sciences·2023
Same author

Association between childhood sexual abuse and early sexual debut among Chinese adolescents: The role of sexual and reproductive health education.

Frontiers in reproductive health·2023
Same author

Effect of intraoperative dexmedetomidine on long-term survival in older patients after major noncardiac surgery: 3-year follow-up of a randomized trial.

Journal of clinical anesthesia·2023
Same author

Whole-genome resequencing reveals genetic differences and the genetic basis of parapodium number in Russian and Chinese Apostichopus japonicus.

BMC genomics·2023
Same author

VPAC2 receptor mediates VIP-potentiated insulin secretion via ion channels in rat pancreatic β cells.

Experimental cell research·2023
Same author

Nanoplastics affect the growth of sea urchins (Strongylocentrotus intermedius) and damage gut health.

The Science of the total environment·2023

相关实验视频

Updated: Jun 30, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K

在早期的甲基慢性第二次原发性肺癌中通过淋巴切除术改善生存率:回顾性分析.

Jieshi Zhang1, Yuxiao Lin2, Jiong Zhou1

  • 1Department of Medical Affairs, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Oncology research and treatment
|March 17, 2024
PubMed
概括

淋巴切除术改善了早期甲基慢性第二原发性肺癌 (MSPLC) 的生存率. 这项研究发现,与没有接受淋巴切除术的MSPLC患者相比,MSPLC患者的生存益处显著.

关键词:
淋巴结切除术是指淋巴结切除术.甲时性第二次原发性瘤.非小细胞肺癌是非小细胞肺癌.预测 预后 预测 预测

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

263
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.1K

相关实验视频

Last Updated: Jun 30, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

263
Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
07:44

Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay

Published on: March 12, 2018

10.1K

科学领域:

  • 胸部外科手术 胸部外科手术
  • 手术瘤学手术瘤学
  • 肺部医学 肺部医学

背景情况:

  • 淋巴切除术对于可切除的初级肺癌至关重要.
  • 淋巴切除术在早期甲基慢性第二原发性肺癌 (MSPLC) 的预后意义尚不清楚.
  • 这项研究评估了淋巴切除术对MSPLC存活率的影响.

研究的目的:

  • 在早期MSPLC中评估淋巴切除术的预后价值.
  • 为了比较MSPLC患者与没有淋巴切除术的整体存活率.
  • 为MSPLC管理中的外科决策提供证据.

主要方法:

  • 使用SEER数据库 (2004-2015) 进行回顾性队列研究.
  • 包括为第一阶段MSPLC手术治疗的患者.
  • 用于分析的倾向得分匹配和考克斯比例危险模型.

主要成果:

  • 在920名患者中,574人接受了淋巴切除术.
  • 倾向性得分匹配创建了可比较的组,每组为255名患者.
  • 淋巴切除术组显示了更高的5年整体存活率 (58.7%对43.9%,HR 0.76,p=0.002).

结论:

  • 淋巴切除术与在I阶段MSPLC中改善整体存活率有关.
  • 这些发现支持将淋巴切除术纳入MSPLC手术管理.
  • 这为治疗MSPLC的胸部外科医生提供了指导.